Antisaccades as a follow-up tool in major depressive disorder therapies: A pilot study

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 1051-1053

  Malsert, Jennifer ^a   Guyader, Nathalie ^b   Chauvin, Alan ^a   Polosan, Mircea ^c,d,e   Poulet, Emmanuel ^f   Szekely, David ^c,d,e   Bougerol, Thierry ^a,c   Marendaz, Christian ^a  

^a UNIVERSITÉ PIERRE MENDÈS FRANCE   (France)

^b CNRS   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIV GRENOBLE ALPES   (France)

^e GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

DLPFC; Inhibition; Mood disorder

Indexed keywords

PLACEBO; VENLAFAXINE;

ADULT; ANTISACCADE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LATENT PERIOD; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SYSTEMATIC ERROR; TASK PERFORMANCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; VOLUNTARY MOVEMENT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SACCADES; TREATMENT OUTCOME;

EID: 84872398082     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.05.007     Document Type: Article

References (21)

1. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., Gerner R.H., Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 1989, 46(3):243-250.
2. Bench C.J., Frackowiak R.S., Dolan R.J. Changes in regional cerebral blood flow on recovery from depression. Psychological Medicine 1995, 25(2):247-261.
3. Chauvin A., Guyader N., Braun M.N., Quetard B., Marendaz C. Reliability and sensitivity of anti saccade in a block versus mixed paradigm. Journal of Vision 2011, 11(11):551. 10.1167/11.11.551.
4. Crevits L., Van den Abbeele D., Audenaert K., Goethals M., Dierick M. Effect of repetitive transcranial magnetic stimulation on saccades in depression: a pilot study. Psychiatry Research 2005, 135(2):113-119.
5. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biological Psychiatry 2002, 51(1):68-80.
6. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2002, 12(6):527-544.
7. Everling S., Dorris M.C., Klein R.M., Munoz D.P. Role of primate superior colliculus in preparation and execution of anti-saccades and pro-saccades. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1999, 19(7):2740-2754.
8. Fukushima J., Fukushima K., Morita N., Yamashita I. Disturbances in the control of saccadic eye movement and eye-head coordination in schizophrenics. Journal of Vestibular Research: Equilibrium and Orientation 1990, 1(2):171-180.
9. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., Hallett M., Post R.M. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995, 6(14):1853-1856.
10. Gooding D.C., Basso M.A. The tell-tale tasks: a review of saccadic research in psychiatric patient populations. Brain and Cognition 2008, 68(3):371-390.
11. Gooding D.C., Mohapatra L., Shea H.B. Temporal stability of saccadic task performance in schizophrenia and bipolar patients. Psychological Medicine 2004, 34(5):921-932.
12. Guyader N., Malsert J., Marendaz C. Having to identify a target reduces latencies in prosaccades but not in antisaccades. Psychological Research 2010, 74(1):12-20.
13. Harris M.S., Reilly J.L., Keshavan M.S., Sweeney J.A. Longitudinal studies of antisaccades in antipsychotic-naïve first-episode schizophrenia. Psychological Medicine 2006, 36(4):485-494.
14. Kallimani D., Theleritis C., Evdokimidis I., Stefanis N.C., Chatzimanolis I., Smyrnis N. The effect of change in clinical state on eye movement dysfunction in schizophrenia. European Psychiatry 2009, 24(1):17-26.
15. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. The American Journal of Psychiatry 2001, 158(6):899-905.
16. Munoz D.P., Everling S. Look away: the anti-saccade task and the voluntary control of eye movement. Nature Reviews Neuroscience 2004, 5(3):218-228.
17. Muri R.M., Nyffeler T. Using transcranial magnetic stimulation to probe decision-making and memory. Progress in Brain Research 2008, 171:413-418.
18. Nyffeler T., Muri R.M., Bucher-Ottiger Y., Pierrot-Deseilligny C., Gaymard B., Rivaud-Pechoux S. Inhibitory control of the human dorsolateral prefrontal cortex during the anti-saccade paradigm-a transcranial magnetic stimulation study. The European Journal of Neuroscience 2007, 26(5):1381-1385.
19. Pierrot-Deseilligny C., Muri R.M., Ploner C.J., Gaymard B., Rivaud-Pechoux S. Cortical control of ocular saccades in humans: a model for motricity. Progress in Brain Research 2003, 142:3-17.
20. Radant A.D., Dobie D.J., Calkins M.E., Olincy A., Braff D.L., Cadenhead K.S., Freedman R., Green M.F., Greenwood T.A., Gur R.E., Light G.A., Meichle S.P., Mintz J., Nuechterlein K.H., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang M.T., Turetsky B.I., Tsuang D.W. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophrenia Research 2007, 89(1-3):320-329.
21. Sweeney J.A., Mintun M.A., Kwee S., Wiseman M.B., Brown D.L., Rosenberg D.R., Carl J.R. Positron emission tomography study of voluntary saccadic eye movements and spatial working memory. Journal of Neurophysiology 1996, 75(1):454-468.